Article info
PDFClinical and epidemiological research
Concise report
Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?
- Correspondence to Dr Marieke H Otten, Department of Paediatrics, Erasmus MC Sophia Children's Hospital, Office Sp 1546, PO Box 2060, 3000 CB Rotterdam, The Netherlands; m.otten{at}erasmusmc.nl
Citation
Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?
Publication history
- Accepted August 11, 2010
- First published November 10, 2010.
Online issue publication
January 13, 2011
Article Versions
- Previous version (10 November 2010).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions